U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363837) titled 'Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants' on Jan. 05.
Brief Summary: This trial employs a randomized, double-blind, placebo/positive control, and dose-finding design to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of SIBP-A16 injection in premature and term infants.
Study Start Date: Jan. 15
Study Type: INTERVENTIONAL
Condition:
Respiratory Syncytial Virus (RSV)
Intervention:
DRUG: SIBP-A16 injection
Strength: dose 1, dose 2 and dose 3. Single administration via intramuscular or intravenous injection.
DRUG: ...